SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
Paola Cassis(Mario Negri Institute for Pharmacological Research), Carla Zoja(Mario Negri Institute for Pharmacological Research)
Cited by 172
Related Papers
<i>MYO1E</i>Mutations and Childhood Familial Focal Segmental Glomerulosclerosis
|New England Journal of Medicine|2011|251
Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling
|American Journal Of Pathology|2006|99